Skip to main content

Investigating the Role of the Psychedelic Experience in the Antidepressant Response in Patients With Major Depression: a Placebo-controlled Factorial Trial With DMT Masked With Propofol (DMT4D-Study)

El objetivo de este estudio es dilucidar si el efecto antidepresivo de la N,N-dimetiltriptamina (DMT) se basa en mecanismos biológicos que incluyen la neuroplasticidad y el efecto antiinflamatorio, o si se debe a la experiencia psicodélica subjetiva.

Status
recruiting
Institution
University Hospital, Basel, Switzerland
Principal investigator
Matthias Liechti, Prof. Dr. med.
Start date
2025-08-05
End date
2029-03-01
Registry ID
NCT06927076

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.